Clinical Trial Update: Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy

View source ↗

Summary

This clinical trial explores how neoadjuvant therapy reshapes the MHC-related immune microenvironment in muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Muscle-invasive Bladder Cancer | Status: NOT_YET_RECRUITING